Press Releases

Varian Congratulates Historic Trade Package Agreement with Brazil

Varian (NYSE: VAR) congratulates the United States Trade Representative and the Ministry of Development, Industry and Foreign Trade of Brazil on achieving the first steps of a trade agreement...

Varian Announces Presence at American Society for Radiation Oncology (ASTRO) Annual Meeting Highlighting Advancements in Intelligent Cancer Care™

Varian (NYSE: VAR), a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care™ during the 2020 American Society...

Varian Announces Fourth Quarter Fiscal Year 2020 Earnings Release Date

Varian (NYSE: VAR) today announced its fourth quarter of fiscal year 2020 earnings release date. The Company will report results for the fourth quarter of fiscal year 2020 after market close on...

Varian Stockholders Approve Combination with Siemens Healthineers

Varian (NYSE: VAR) today announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG (Frankfurt: SHL) at a special meeting....

Varian Receives Investigational Device Exemption (IDE) and Prepares for First Ever Clinical Trial of FLASH Therapy

Varian (NYSE: VAR) today announced the company has received an Investigational Device Exemption (IDE) from the Food and Drug Administration (FDA) for the first-ever clinical trial of FLASH...

Varian Expects to Benefit from the Extension of Medical Linear Accelerators Tariff Exclusion in China

Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that the first exclusion of the additional tariffs China imposed on US products will expire...

Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1

Highlights: Integration of Dual Energy CT (DECT) images in the Eclipse planning process reduces range uncertainty and helps clinicians' spare healthy tissue. Graphics Processing Unit (GPU)...

Varian Announces Appointment of Chris Toth as President and Chief Operating Officer

Varian (NYSE: VAR) today announced the following leadership appointments, effective October 5, 2020: Chris Toth, Varian Oncology Systems President, has been appointed to the newly created role of...

Varian Announces Goshen Center for Cancer Care Treats First Patient with Ethos® Therapy, Expanding Access to Personalized Cancer Care

Varian (NYSE: VAR) today announced the Goshen Center for Cancer Care in Goshen, Ind., treated its first patient with Ethos™ therapy, marking the first availability of this advanced cancer...

Germany's first Ethos Therapy Ordered by the German Cancer Research Center

Varian (NYSE: VAR) today announced the German Cancer Research Center (DKFZ) in Heidelberg has ordered Germany's first Ethos™ therapy, an Adaptive Intelligence™ solution. This artificial...